Insite: Canada's landmark safe injecting program at risk
2006

InSite: Canada's Landmark Safe Injecting Program at Risk

Sample size: 7200 Editorial Evidence: high

Author Information

Author(s): Ernest Drucker

Primary Institution: Montefiore Medical Centre

Conclusion

The potential closure of InSite could lead to significant public health risks and economic costs for Vancouver and British Columbia.

Supporting Evidence

  • InSite has led to increased admissions to local detoxification programs and addiction treatment.
  • InSite has not led to an increase in drug-related crime.
  • InSite has reduced the number of people injecting in public.
  • InSite is attracting the highest-risk users.
  • InSite has reduced overall rates of needle sharing in the community.
  • InSite users are more likely to receive information on safer injecting practices.
  • InSite is not increasing rates of relapse among former drug users.

Takeaway

InSite is a safe place for people to use drugs, and if it closes, many people could get hurt and it would cost a lot of money.

Participant Demographics

Active intravenous drug users, primarily in Vancouver's Downtown Eastside.

Digital Object Identifier (DOI)

10.1186/1477-7517-3-24

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication